前药
TLR4型
炎症
化学
硝基还原酶
酶
药理学
药品
催化作用
Toll样受体
受体
生物化学
先天免疫系统
医学
免疫学
作者
Michael A. Plunk,Alyssa Alaniz,Olatunde P. Olademehin,Thomas L. Ellington,Kevin L. Shuford,Robert R. Kane
标识
DOI:10.1021/acsmedchemlett.9b00518
摘要
Tak-242 (resatorvid), a Toll-like Receptor 4 (TLR4) inhibitor, has been identified as a potent suppressor of innate inflammation. As a strategy to target Tak-242 to select tissue, four TLR4-inactive prodrugs were synthesized for activation via two different release mechanisms. Two nitrobenzyl Tak-242 prodrugs released the parent drug upon exposure to the exogenous enzyme nitroreductase, while the two propargyl prodrugs were converted to Tak-242 in the presence of Pd 0 .
科研通智能强力驱动
Strongly Powered by AbleSci AI